• 1. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 5. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220

Introduction to 2,5-dimethyl-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (CAS No. 1309980-12-8) and Its Applications in Modern Chemical Biology

2,5-dimethyl-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, identified by the Chemical Abstracts Service Number (CAS No.) 1309980-12-8, is a specialized organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound belongs to the class of borylated pyridines, which are widely recognized for their utility in cross-coupling reactions and as intermediates in the synthesis of biologically active molecules. The unique structural features of this compound, particularly the presence of a tetramethylborate group, make it a valuable tool in the development of novel therapeutic agents.

The tetramethyl-1,3,2-dioxaborolan-2-yl moiety in the molecular structure of 2,5-dimethyl-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine is a key functional group that facilitates its role as a boronic acid derivative. Boronic acids and their derivatives are well-known for their participation in Suzuki-Miyaura cross-coupling reactions, which are fundamental transformations in modern organic synthesis. These reactions allow for the efficient construction of carbon-carbon bonds and have been extensively employed in the preparation of complex molecular architectures. The stability and reactivity of the boronate ester functionality make this compound particularly useful in synthetic applications where high yields and selectivity are required.

In recent years, there has been a surge in research focused on developing new methodologies for the functionalization of heterocyclic compounds. Pyridine derivatives, including 2,5-dimethyl-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, have emerged as crucial building blocks in medicinal chemistry due to their prevalence in many biologically active natural products and synthetic drugs. The ability to introduce boron-containing groups into pyridine frameworks provides chemists with additional handles for further derivatization, enabling the exploration of novel pharmacophores.

One of the most compelling aspects of 2,5-dimethyl-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine is its potential application in the synthesis of small-molecule inhibitors targeting various disease-related pathways. For instance, recent studies have highlighted the importance of pyridine-based compounds in modulating enzyme activity and interacting with biological macromolecules. The borylated pyridine scaffold can be readily incorporated into drug-like molecules through cross-coupling reactions with aryl halides or alkynes, providing a versatile platform for structure-based drug design.

The use of tetramethylborate derivatives offers several advantages over traditional boronic acids. The bulky methyl groups surrounding the boron atom enhance steric hindrance, which can improve reaction efficiency by minimizing side reactions. Additionally, the increased lipophilicity conferred by these substituents can enhance membrane permeability, making such compounds more suitable for oral administration. These properties have been exploited in recent research efforts aimed at developing next-generation antiviral and anticancer agents.

Recent advancements in flow chemistry have also demonstrated the utility of 2,5-dimethyl-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine in continuous-flow processes. Flow chemistry allows for precise control over reaction conditions and scalability, making it an attractive approach for industrial applications. By integrating borylation reactions into flow systems, researchers can achieve higher reproducibility and throughput compared to traditional batch processes. This has opened up new possibilities for large-scale synthesis and process optimization.

The compound's role extends beyond synthetic intermediates; it has also been explored as a ligand in catalytic systems. Transition metal-catalyzed reactions involving borylated pyridines have shown promise in facilitating complex bond-forming events under mild conditions. Such catalytic approaches are essential for sustainable chemistry and have been recognized with numerous awards and accolades in the scientific community.

In conclusion, 2,5-dimethyl-3-(tetramethyl-1,3,2-dioxaborolan-2-ylyl)pyridine (CAS No. 1309980 12 8) represents a significant advancement in chemical biology and pharmaceutical research. Its unique structural features and reactivity make it an indispensable tool for synthetic chemists working on drug discovery programs. As our understanding of molecular interactions continues to evolve, tetramethylborate-containing derivatives will undoubtedly play an increasingly important role in shaping the future of medicinal chemistry.

• 1012084-56-8(2-Methylpyridine-3-boronic acid, pinacol ester)
• 693774-10-6(2,6-Dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 1622217-32-6(4,6-Dimethylpyridine-3-boronic Acid Pinacol Ester)
• 1421252-89-2(2,4-dimethyl-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 1815616-21-7(Tazemetostat Impurity 2)
• 1309443-99-9(2,5-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine (>90%))
• 2304634-94-2(5-Methyl-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carbonitrile)
• 2223012-08-4(6-methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-carbonitrile)
• 741709-65-9(2,3-Dimethylpyridine-5-boronic acid pinacol ester)
• 2096331-29-0(Pyridine, 2,4,6-trimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-)